Cancer Predispositions

Breast and ovarian cancers can develop due to genetic mutations that impair DNA repair mechanisms, leading to uncontrolled cell growth. 

This test analyses specific variations in genes responsible for tumour suppression and DNA repair. Mutations in these genes can lead to a lifetime likelihood of breast cancer to over 80%. Identifying mutations that significantly increase cancer risk helps you and your healthcare provider make informed health decisions. Early detection is crucial in breast and ovarian cancers, as it can greatly improve treatment outcomes. By knowing your risk, you and your healthcare provider can make informed decisions about monitoring and preventive strategies.

Colorectal cancer is the second leading cause of cancer deaths globally, with cases expected to rise by 71.5% by 2035. Risk factors include unhealthy lifestyle choices like poor diet, obesity, excessive alcohol consumption, smoking, and genetic predisposition.

This test detects mutations in genes that regulate cell division and inhibit tumour growth. These mutations significantly increase the risk of conditions like familial adenomatous polyposis coli (FAP) and hereditary mixed polyposis syndrome (HMPS), which can lead to cancer. Early detection and awareness empower you to adopt healthier habits and engage in monitoring strategies, which is crucial given the rising prevalence of this serious disease.

Lung cancer is the second most common cancer and the leading cause of cancer deaths worldwide. While smoking is the main cause, genetic factors also significantly impact risk by affecting how your body handles harmful substances like nicotine. 

This test analyses specific genes that are responsible for the production of proteins that inhibit the growth and reproduction of damaged cells, as well as regulate the aging process of cells and the binding of harmful substances entering the lungs, including nicotine. Abnormalities in the indicated genes result in the formation of a protein that does not respond to DNA damage, increases the negative effects of smoking and the risk of addiction to nicotine, thus leading to a much greater risk of respiratory cancer.

Pancreatic cancer is seventh among cause of death from cancer. This type of cancer is highly lethal and is still characterised by low 5-year survival rate. Pancreatic cancer is more frequent in developed countries.

This test analyses specific variations that impair enzyme production in the pancreas, leading to chronic inflammation and increasing cancer risk. These genetic mutations affect enzymes essential for protein digestion and protecting the pancreas from self-damage. By identifying these variations, you and your healthcare provider can take proactive steps for monitoring and prevention, empowering you to make informed health decisions.

Prostate cancer is the third most common cancer in men. While it primarily affects men over 60, cases in younger men are on the rise. Risk factors include age, obesity, smoking, lack of activity, and notably, genetic predisposition.

This test analyses specific genetic variations that impair proteins responsible for preventing tumour development. Mutations in these genes may account for 30-40% of early-onset prostate cancer cases. Understanding your genetic predisposition empowers you to take proactive steps - such as regular screenings and lifestyle adjustments - for early detection and effective treatment.

Skin cancer, including melanoma, arises from abnormal skin cell growth, often due to UV exposure. Genetic factors significantly increase melanoma risk.

This test detects mutations in genes that are responsible for the production of proteins that inhibit the development of skin cancer, as well as for proper pigmentation, which is crucial for the protection of the skin. These variations can impair proteins that prevent cancer, raising your risk. By identifying these variations, you and your healthcare provider can take proactive steps for monitoring and prevention, empowering you to make informed health decisions.